Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.

Mrózek K, Prior TW, Edwards C, Marcucci G, Carroll AJ, Snyder PJ, Koduru PR, Theil KS, Pettenati MJ, Archer KJ, Caligiuri MA, Vardiman JW, Kolitz JE, Larson RA, Bloomfield CD.

J Clin Oncol. 2001 May 1;19(9):2482-92.

PMID:
11331327
2.

Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?

Marcucci G, Caligiuri MA, Bloomfield CD.

Eur J Haematol. 2003 Sep;71(3):143-54. Review.

PMID:
12930314
3.

Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.

Viswanatha DS, Chen I, Liu PP, Slovak ML, Rankin C, Head DR, Willman CL.

Blood. 1998 Mar 15;91(6):1882-90.

4.

Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.

Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Watmore AE, Bown NP.

Br J Haematol. 2000 Dec;111(4):1051-6.

PMID:
11167739
5.
6.

Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.

Tobal K, Johnson PR, Saunders MJ, Harrison CJ, Liu Yin JA.

Br J Haematol. 1995 Sep;91(1):104-8.

PMID:
7577615
7.

Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.

Merchant SH, Haines S, Hall B, Hozier J, Viswanatha DS.

J Mol Diagn. 2004 Aug;6(3):271-4.

8.

Dual color FISH on CBF primary acute myeloid leukemia.

Sorour A, Nafea D.

Egypt J Immunol. 2008;15(2):25-31.

PMID:
20306685
9.
10.

Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).

Zhao W, Claxton DF, Medeiros LJ, Lu D, Vadhan-Raj S, Kantarjian HM, Nguyen MH, Bueso-Ramos CE.

Am J Surg Pathol. 2006 Nov;30(11):1436-44.

PMID:
17063086
11.

Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.

Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carroll AJ, Behm F, et al.

Blood. 1995 Jun 15;85(12):3695-703.

12.

Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.

Marcucci G, Caligiuri MA, Döhner H, Archer KJ, Schlenk RF, Döhner K, Maghraby EA, Bloomfield CD.

Leukemia. 2001 Jul;15(7):1072-80.

PMID:
11455976
13.

Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias.

Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J, et al.

Blood. 1995 Mar 1;85(5):1313-22.

14.

Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.

Mitterbauer M, Kusec R, Schwarzinger I, Haas OA, Lechner K, Jaeger U.

Ann Hematol. 1998 Mar-Apr;76(3-4):139-43.

PMID:
9619731
15.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

16.

Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.

Ichikawa H, Tanabe K, Mizushima H, Hayashi Y, Mizutani S, Ishii E, Hongo T, Kikuchi A, Satake M.

Br J Haematol. 2006 Nov;135(3):336-47. Epub 2006 Sep 21.

PMID:
16989659
17.

FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.

Dierlamm J, Stul M, Vranckx H, Michaux L, Weghuis DE, Speleman F, Selleslag D, Kramer MH, Noens LA, Cassiman JJ, Van den Berghe H, Hagemeijer A.

Genes Chromosomes Cancer. 1998 Jun;22(2):87-94. Review.

PMID:
9598794
18.

Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing.

Sarriera JE, Albitar M, Estrov Z, Gidel C, Aboul-Nasr R, Manshouri T, Kornblau S, Chang KS, Kantarjian H, Estey E.

Leukemia. 2001 Jan;15(1):57-61.

PMID:
11243400
19.

Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.

Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AM, Knuutila S, Herzig GP, Bloomfield CD.

Blood. 1996 Sep 15;88(6):2183-91.

20.

Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.

de Greef GE, Hagemeijer A, Morgan R, Wijsman J, Hoefsloot LH, Sandberg AA, Sacchi N.

Leukemia. 1995 Feb;9(2):282-7.

PMID:
7869765

Supplemental Content

Support Center